Argenx
ARGX
#422
Rank
A$84.59 B
Marketcap
A$1,345
Share price
3.63%
Change (1 day)
0.49%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: A$84.59 Billion

As of November 2026 Argenx has a market cap of A$84.59 Billion. This makes Argenx the world's 422th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026A$84.59 B7.68%
2025A$78.55 B30.47%
2024A$60.21 B81.78%
2023A$33.12 B7.55%
2022A$30.79 B21.41%
2021A$25.36 B39.11%
2020A$18.23 B85.61%
2019A$9.82 B97.4%
2018A$4.97 B93.8%
2017A$2.56 B
2014A$0.17 B

End of Day market cap according to different sources

On Nov 8th, 2026 the market cap of Argenx was reported to be:

A$83.48 Billion
by Nasdaq info icon info icon
A$84.59 Billion
by CompaniesMarketCap info icon info icon